Origin Genomics aims to prove the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks.
(Image credit: Mackenzie Calle for NPR)
Origin Genomics aims to prove the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks.(Image credit: Mackenzie Calle for NPR)
Origin Genomics aims to prove the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks.
(Image credit: Mackenzie Calle for NPR)